C
China Medical System Holdings Ltd
HKEX:867
China Medical System Holdings Ltd
HKEX:867
Price:
15.33
HKD
1.32%
Market Closed
Market Cap:
HK$37.4B
Relative Value
The Relative Value of one China Medical System Holdings Ltd stock under the Base Case scenario is 9.15 HKD. Compared to the current market price of 15.33 HKD, China Medical System Holdings Ltd is Overvalued by 40%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
9.15
HKD
Overvaluation 40%
C
Multiples Across Competitors
Competitors Multiples
China Medical System Holdings Ltd Competitors
China Medical System Holdings Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
China Medical System Holdings Ltd
HKEX:867
|
37.4B HKD | 4.4 | 21 | 16 | 16 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
982.7B USD | 15.1 | 47.6 | 32.1 | 34.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
294.5B CHF | 4.8 | 31.3 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
243B GBP | 5.7 | 32.5 | 17.9 | 25.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
247.9B CHF | 5.7 | 22.8 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
302.6B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
156.1B USD | 2.5 | 20.1 | 7.5 | 10 | |
| UK |
|
GSK plc
XETRA:GS71
|
105.8B EUR | 2.8 | 16.1 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
